Labcorp announces initiatives to enhance shareholder value

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 9, 2021-- Labcorp (NYSE: LH) (the Company), a leading global life sciences company, today announced actions that its Board of Directors (the Board) and management team have taken to enhance shareholder returns. 

Labcorp completes acquisition of Toxikon corporation

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 3, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation , a contract research organization delivering best-in-class nonclinical testing services.

Labcorp and ConcertAI optimize precision oncology research with real-world data and artificial intelligence

BURLINGTON, N.C. & CAMBRIDGE, Mass. --(BUSINESS WIRE)--Dec. 1, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, and ConcertAI, LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) and real-world data (RWD) solutions for life science companies and health care providers, today announced a collaboration to optimize precision oncology research. The companies will work together to launch clinical studies in ways that minimize the burden on physician practices, drive faster patient recruitment, maximize patient retention and ensure equitable access to research as a care option.

Labcorp now offers observed collection for COVID-19 PCR testing in over 500 locations nationwide, with plans to Expand to more than 1,000 locations

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 30, 2021-- Labcorp (NYSE: LH), a global life sciences company, is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers (PSCs) nationwide for people without symptoms or known exposure. By mid-December, the company plans to further expand the COVID-19 PCR test collection service to over 1,000 locations.